Pharmacovigilance in radiopharmaceuticals.
Indian Pharmacopoeia Commission is Committed for maintaining the standards of drugs including Radiopharmaceuticals (RPs) by publishing Indian Pharmacopoeia. These RPs are being used in India for diagnostic or therapeutic purpose. RPs though contain relatively small quantities of active ingredient and administered in small volumes could cause some adverse reactions to the patients. The objective of presenting this article is to introduce the system of adverse drug reaction reporting to the nuclear medicine fraternity who are dealing with RPs.
Pharmacovigilance Division, Indian Pharmacopoeia Commission, National Coordination Centre-Pharmacovigilance Programme of India, India.
Rishi
R
Kumar
Pharmacovigilance Division, Indian Pharmacopoeia Commission, Ghaziabad, Uttar Pradesh, India.
Vivekanandan
V
Kalaiselvan
Pharmacovigilance Division, Indian Pharmacopoeia Commission, National Coordination Centre-Pharmacovigilance Programme of India, India.
Rakesh
R
Kumar
Pharmacovigilance Division, Indian Pharmacopoeia Commission, Ghaziabad, Uttar Pradesh, India.
Ravendra
R
Verma
Pharmacovigilance Division, Indian Pharmacopoeia Commission, Ghaziabad, Uttar Pradesh, India.
Gyanendra Nath
GN
Singh
Adverse drug reactions; pharmacovigilance; radiopharmaceuticals